Currently available murine staphylococcal enterotoxin B (SEB) shock models require pretreatment with various agents to increase mouse sensitivity to SEB. This study was performed to show that C3H/HeJ mice are highly susceptible to intranasal SEB inoculation, which caused toxic shock without using pretreatment agents. For this purpose, mice were injected intranasally with different doses of SEB and observed for up to 1 month. The median lethal dose of SEB was determined using the probit procedure. Tissue samples were taken at different time points for histopathological examination. The LD50 was found at 1.6 μg/g (95% fiducial limit (f.l.) 0.7 to 2.2), the LD80 at 2.7 μg/g (95% f.l. 1.9 to 4.0) and the LD90 at 3.6 μg/g (95% f.l. 2.7 to 6.4). Histopathologic examination revealed pulmonary edema and bronchopneumonia. Mucosal-associated lymphoid tissue first became activated, followed by increasing lymphocyte apoptosis and depletion. In the liver there were intralobular and portal inflammatory foci with increasing lymphocyte apoptosis and degenerative necrosis. The splenic white pulp was characterized by early activation and subsequent depletion of lymphoid follicle germinal centers. The thymus initially was activated, followed by increasing apoptosis and migration of lymphoid cells from the cortex to the medulla. The pathological features detected in the mice were similar to those of rhesus monkeys treated with SEB aerosol challenge.
Anderson MR, Tary-Lehmann M. (2001). Staphylococcal enterotoxin-B-induced lethal shock in mice is T-cell-dependent, but disease susceptibility is defined by the non-T-cell compartment. Clin Immunol98(1): 85—94.
2.
Assenmaher M. , Lohning M., Scheffold A., Manz RA, Schmitz J., Radbruch A. (1998). Sequential production of IL-2, IFN-gamma and IL-10 by individual staphylococcal enterotoxin B-activated T helper lymphocytes. Eur J Immunol28(5): 1534—1543.
3.
Baccala R., Vandekerckhove BA, Jones D., Kono DH, Roncarolo MG, Theofilopoulos AN (1993). Bacterial superantigens mediate T cell deletions in the mouse severe combined immunodeficiency-human liver/thymus model. J Exp Med177(5): 1481—1485.
4.
Beisel WR (1972). Pathophysiology of staphylococcal enterotoxin, type B, (SEB) toxemia after intravenous administration to monkeys. Toxicon10(5): 433—440.
5.
Benjamin MA, Lu J., Donnelly G., Dureja P., McKay DM (1998). Changes in murine jejunal morphology evoked by the bacterial superantigen Staphylococcus aureus enterotoxin B is mediated by CD4+ T cells. Infect Immun66(5): 2193—2199.
6.
Berg MS (1983). Enterotoxins. In: Staphylococci and Staphylococcal Infections, Easmon CSF and Adams C (eds). vol. 2. Academic Press, Ltd., London, pp. 187—243.
7.
Blank C., Luz A., Bendigs S., Erdmann A., Wagner H., Heeg K. ( 1997). Superantigen and endotoxin synergize in the induction of lethal shock. Eur J Immunol27(4): 825—833.
8.
Center for Disease Control ( 1981). Food-borne outbreaks. Annual Summary 1981. Center for Disease Control, Atlanta.
9.
Chen JY, Qiao Y., Komisar JL, Baze WB, Hsu IC, Tseng J. (1994). Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D. Infect Immun62(10): 4626—4631.
10.
Choi Y., Kotzin B., Herron L., Callahan J., Marrack P., Kappler J. (1989). Interaction of Staphylococcus aureus toxin “superantigens” with human T cells. Proc Nat Acad Sci USA86(22): 8941—8945.
11.
Datta S., Bhattacharyya P. (2001). Effect of an herbal protein CI-1, purified from Cajanus indicus on the ultrastructural study of hepatocytes, in models of liver failure in mice. J Ethnopharmacol77(1): 2001.
12.
Fujiki M., Shinbori T., Suga M., Miyakawa H., Ando M. ( 1999). Role of T cells in bronchoalveolar space in the development of interstitial pneumonia induced by superantigen in autoimmune-prone mice . Am J Respir Cell Mol Biol21(6): 675—683.
13.
Johnson HM, Russell JK, Pontzer CH (1991). Staphylococcal enterotoxins microbial superantigen . FASEB J5(12): 2706—2712.
14.
Kappler J., Kotzin B., Herron L., Gelfand EW, Bigler RD, Boylston L., Carrel S., Posnett DN, Choi Y., Marrack P. (1989). V-beta specific stimulation of human T cells by staphylococcal toxins. Science244(4906): 811— 813.
15.
Khullar M., Chatterjee S. (1995). Staphylococcal enterotoxin-B (SEB) alters [14C]-choline transport and phosphatidylcholine metabolism in cultured human kidney proximal tubular cells. Mol Cell Biochem146(2): 115—20.
16.
Komisar J., Rivera J., Vega A., Tseng J. (1992). Effects of staphylococcal enterotoxin B on rodent mast cells. Infect Immun60(7): 2969—2975.
17.
Komisar JL, Weng CF, Oyejide A., Hunt RE, Briscoe C., Tseng J. (2001). Cellular and cytokine responses in the circulation and tissue reactions in the lung of rhesus monkeys (Macaca mulatta) pretreated with cyclosporin A and challenged with staphylococcal enterotoxin B. Toxicol Pathol29(3): 369—378.
Leist M., Gantner F., Naumann H., Bluethmann H., Vogt K., Brigelius-Flohe R., Nicotera P., Volk HD, Wendel A. (1997). Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins. Gastroenterology112(3): 923—934.
20.
Lin YS, Huang YT, Chen PS, Lin CF, Jan MS, Lei HY (1999). Requirement of I-E molecule for thymocyte apoptosis induced by staphylococcal enterotoxin B in vivo. Cell Immunol.193(1): 71—79.
21.
Lin YS, Lei HY, Low TL, Shen CL, Chou LJ, Jan MS (1992). In vivo induction of apoptosis in immature thymocytes by staphylococcal enterotoxin B. J Immunol149(4): 1156—1163.
22.
Mattix ME, Hunt RE, Wilhelmsen CL, Johnson AJ, Baze WB ( 1995). Aerosolized staphylococcal enterotoxin B-induced pulmonary lesions in rhesus monkeys (Macaca mulatta). Toxicol Pathol23(3): 262—268.
23.
McKay DM (2001). Bacterial superantigens: Provocateurs of gut dysfunction and inflammation?Trends Immunol22(9): 497—501.
24.
Miethke T., Wahl C., Heeg K., Echtenacher B., Krammer PH, Wagner H. (1992). T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: Critical role of tumor necrosis factor. J Exp Med175(1): 91—98.
25.
Nagaki M., Tanaka M., Sugiyama A., Ohnishi H., Moriwaki H. (1999) Interleukin-10 inhibits hepatic injury and tumor necrosis factor-alpha and interferon-gamma mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosamine-sensitized mice. J Hepatol31(5): 815—824.
26.
Parrillo JE (1993). Pathogenetic mechanisms of septic shock. N Engl J Med328(20): 1471—1478.
27.
Parrilo JE, Parker MM, Natanson C., Suffredini AF, Danner RL, Cunnion RE, Ognibene FP (1990). Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med113(3): 227—242.
28.
Perkins DL, Wang Y., Ho SS, Wiens GR, Seidman JG, Rimm IJ ( 1993). Superantigen-induced peripheral tolerance inhibits T cell responses to immunogenic peptides in TCR (beta-chain) transgenic mice . J Immunol150(10): 4284—4291.
29.
Raj HD, Bergdoll MS (1969). Effect of enterotoxin B on human volunteers. J Bacteriol98(2): 833—834.
30.
Rogers TJ, Zhang L. (1997). Structural basis for the interaction of superantigen with the alternative superantigen-binding receptor p85. Mol Immunol34(3): 263—272.
31.
SAS Institute Inc. (1999). SAS/STAT User's Guide, Version 8, Cary, NC: SAS Institute Inc.
32.
Schantz EJ, Roessler WG, Wagman J., Spero L., Dunnery DA, Bergdoll MS (1965). Purification of staphylococcal enterotoxin B. Biochemistry4(6): 1011—1016.
33.
Schlievert PM (1986). Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet1(8490): 1149—1150.
34.
Shinbori T. , Matsuki M., Suga M., Kakimoto K., Ando M. (1996). Induction of interstitial pneumonia in autoimmune mice by intratracheal administration of superantigen staphylococcal enterotoxin B. Cell Immunol174(2): 129— 137.
35.
Spiekermann GM, Nagler-Anderson C. (1998). Oral administration of the bacterial superantigen staphylococcal enterotoxin B induces activation and cytokine production by T cells in murine gut-associated lymphoid tissue. J Immunol161(11): 5825—5831.
36.
Stiles BG, Bavari S., Krakauer T., Ulrich RG (1993). Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: Major histocompatibility complex class II molecule dependency and cytokine release. Infect Immun61(12): 5333—5338.
37.
Tessier PA, Naccache PH, Diener KR, Galdue RP, Neote KS, Clark-Lewis I., McColl SR (1998). Induction of acute inflammation in vivo by staphylococcal superantigens. II. Critical role for chemokines, ICAM-1, and TNF-alpha. J Immunol161(3): 1204—1211.
38.
Tiegs G., Gantner F. (1996). Immunotoxicology of T cell-dependent experimental liver injury. Exp Toxicol Pathol48(5): 471—476.
39.
Tseng J., Komisar J., Chen JY, Hunt RE, Johnson AJ, Pitt L., Rivera J., Ruble DL, Trout R., Vega A. ( 1993). Immunity and responses of circulating leukocytes and lymphocytes in monkeys to aerosolized staphylococcal enterotoxin B. Infect Immun61(2): 391—398.
40.
Vabulas R., Bittlingmaier R., Heeg K., Wagner H., Miethke T. (1996). Rapid clearance of bacterial superantigen staphylococcal enterotoxin B in vivo. Infect Immun64(11): 4567—4573.
41.
Weng CF, Zhao W., Fegeding KV, Komisar JL, Tseng J. (1999). Resistance of Staphylococcal enterotoxin B-induced proliferation and apoptosis to the effects of dexamethasone in mouse lymphocyte cultures. Int Immunol11(5): 787—801.
42.
Wood AC, Todd I. ( 1995). Staphylococcal enterotoxin B toxicity in BALB/c mice: effect on T-cells, plasma cytokine levels and biochemical markers. FEMS Immunol Med Microbiol11(2): 91—97.
43.
Wright SW, Trott AT (1988). Toxic shock syndrome: A review. Ann Emerg Med17(3): 268—273.
44.
Yeung RS, Penninger JM, Kundig T., Khoo W., Ohashi PS, Kroemer G., Mak TW (1996). Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: Supersensitivity to superantigen-induced septic shock. Eur J Immunol26(5): 1074—1082.
